CPEB4 has been reported to exhibit dual roles in tumors, with its protein levels significantly upregulated in early-stage HCC but reduced in late-stage HCC, as observed in paired tumor and adjacent non-tumor liver specimens from 49 HCC patients 15. This evidence concerns the gene CPEB4 and hepatocellular carcinoma.